Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768782354> ?p ?o ?g. }
- W2768782354 endingPage "262" @default.
- W2768782354 startingPage "251" @default.
- W2768782354 abstract "How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR) following primary curative treatment is a controversial issue. Importantly, this prostate-specific antigen (PSA)-only recurrence is a surrogate neither of PCa-specific survival nor of overall survival. Physicians are therefore challenged with preventing or delaying the onset of clinical progression in those deemed at risk, while avoiding over-treating patients whose disease may never progress beyond PSA-only recurrence. Adjuvant therapy for radical prostatectomy (RP) or local radiotherapy (RT) has a role in certain at-risk patients, although it is not recommended in low-risk PCa owing to the significant side-effects associated with RT and androgen deprivation therapy (ADT). The recommendations for salvage therapy differ depending on whether BCR occurs after RP or primary RT, and in either case, definitive evidence regarding the best strategy is lacking. Options for treatment of BCR after RP are RT at least to the prostatic bed, complete or intermittent ADT, or observation; for BCR after RT, salvage RP, cryotherapy, complete or intermittent ADT, brachytherapy, high-intensity focused ultrasound (HIFU), or observation can be considered. Many patient- and cancer-specific factors need to be taken into account when deciding on the best strategy, and optimal management depends on the involvement of a multidisciplinary team, consultation with the patient themselves, and the adoption of an individualised approach. Improvements in imaging techniques may enable earlier detection of metastases, which will hopefully refine future management decisions." @default.
- W2768782354 created "2017-12-04" @default.
- W2768782354 creator A5000840863 @default.
- W2768782354 creator A5011328299 @default.
- W2768782354 creator A5049920253 @default.
- W2768782354 creator A5054933374 @default.
- W2768782354 creator A5083171847 @default.
- W2768782354 date "2017-11-21" @default.
- W2768782354 modified "2023-10-01" @default.
- W2768782354 title "Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review" @default.
- W2768782354 cites W1506304343 @default.
- W2768782354 cites W1510600504 @default.
- W2768782354 cites W1520029619 @default.
- W2768782354 cites W1532841594 @default.
- W2768782354 cites W1546246969 @default.
- W2768782354 cites W1569975580 @default.
- W2768782354 cites W1579723599 @default.
- W2768782354 cites W1859532505 @default.
- W2768782354 cites W1897407769 @default.
- W2768782354 cites W1963034326 @default.
- W2768782354 cites W1968170734 @default.
- W2768782354 cites W1970400785 @default.
- W2768782354 cites W1979048558 @default.
- W2768782354 cites W1979349819 @default.
- W2768782354 cites W1981663805 @default.
- W2768782354 cites W1983138704 @default.
- W2768782354 cites W1985587689 @default.
- W2768782354 cites W1992843821 @default.
- W2768782354 cites W1994258030 @default.
- W2768782354 cites W1995124484 @default.
- W2768782354 cites W2004229786 @default.
- W2768782354 cites W2006088278 @default.
- W2768782354 cites W2007883847 @default.
- W2768782354 cites W2010835716 @default.
- W2768782354 cites W2014999922 @default.
- W2768782354 cites W2017132929 @default.
- W2768782354 cites W2021021529 @default.
- W2768782354 cites W2023126708 @default.
- W2768782354 cites W2023139341 @default.
- W2768782354 cites W2024516085 @default.
- W2768782354 cites W2026385036 @default.
- W2768782354 cites W2028561887 @default.
- W2768782354 cites W2034089192 @default.
- W2768782354 cites W2037733927 @default.
- W2768782354 cites W2040538815 @default.
- W2768782354 cites W2047964070 @default.
- W2768782354 cites W2052927854 @default.
- W2768782354 cites W2058484243 @default.
- W2768782354 cites W2060507029 @default.
- W2768782354 cites W2065024030 @default.
- W2768782354 cites W2065120184 @default.
- W2768782354 cites W2065332029 @default.
- W2768782354 cites W2071879495 @default.
- W2768782354 cites W2072742729 @default.
- W2768782354 cites W2073988927 @default.
- W2768782354 cites W2079361452 @default.
- W2768782354 cites W2081084828 @default.
- W2768782354 cites W2090548200 @default.
- W2768782354 cites W2092700976 @default.
- W2768782354 cites W2093867637 @default.
- W2768782354 cites W2095511137 @default.
- W2768782354 cites W2099149953 @default.
- W2768782354 cites W2100074173 @default.
- W2768782354 cites W2101000894 @default.
- W2768782354 cites W2101285661 @default.
- W2768782354 cites W2104870101 @default.
- W2768782354 cites W2106285196 @default.
- W2768782354 cites W2107270081 @default.
- W2768782354 cites W2107671263 @default.
- W2768782354 cites W2108330864 @default.
- W2768782354 cites W2108864389 @default.
- W2768782354 cites W2109199549 @default.
- W2768782354 cites W2110569728 @default.
- W2768782354 cites W2113957566 @default.
- W2768782354 cites W2119979376 @default.
- W2768782354 cites W2122904975 @default.
- W2768782354 cites W2126267433 @default.
- W2768782354 cites W2131317892 @default.
- W2768782354 cites W2132904157 @default.
- W2768782354 cites W2136437722 @default.
- W2768782354 cites W2136476240 @default.
- W2768782354 cites W2139417264 @default.
- W2768782354 cites W2140754632 @default.
- W2768782354 cites W2142606098 @default.
- W2768782354 cites W2145801780 @default.
- W2768782354 cites W2152283043 @default.
- W2768782354 cites W2152529149 @default.
- W2768782354 cites W2153515948 @default.
- W2768782354 cites W2156306108 @default.
- W2768782354 cites W2162619388 @default.
- W2768782354 cites W2164011896 @default.
- W2768782354 cites W2164980194 @default.
- W2768782354 cites W2167922065 @default.
- W2768782354 cites W2208340908 @default.
- W2768782354 cites W2224015183 @default.
- W2768782354 cites W2229126173 @default.
- W2768782354 cites W2283176855 @default.
- W2768782354 cites W2346061096 @default.